These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 9305675)

  • 1. Side effects of alpha interferon in chronic hepatitis C.
    Dusheiko G
    Hepatology; 1997 Sep; 26(3 Suppl 1):112S-121S. PubMed ID: 9305675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
    Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of hepatitis C: re-treatment with alpha interferon.
    Alberti A; Chemello L; Noventa F; Cavalletto L; De Salvo G
    Hepatology; 1997 Sep; 26(3 Suppl 1):137S-142S. PubMed ID: 9305679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypothyroidism as a complication of the treatment of hepatitis C with interferon].
    Gomollón García F; Simón Marco MA; Vela J; García López S; Fuentes Olmo J
    An Med Interna; 1996 Sep; 13(9):438-40. PubMed ID: 9132035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The neuropsychiatric side effects of the interferon therapy in patients with chronic hepatitis B and C].
    Lapiński TW; Prokopowicz D
    Pol Merkur Lekarski; 1999 Jul; 7(37):8-11. PubMed ID: 10522402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukocyte and platelet lowering by some interferon types during viral hepatitis treatment.
    Toccaceli F; Rosati S; Scuderi M; Iacomi F; Picconi R; Laghi V
    Hepatogastroenterology; 1998; 45(23):1748-52. PubMed ID: 9840140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the effectiveness of interferon alpha treatment for chronic hepatitis C in children.
    Czerwionka-Szaflarska M; Chrobot A; Szaflarska-Szczepanik A
    Med Sci Monit; 2000; 6(5):964-70. PubMed ID: 11208439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Phase I/II study evaluating escalating doses of recombinant human albumin-interferon-alpha fusion protein in chronic hepatitis C patients who have failed previous interferon-alpha-based therapy.
    Balan V; Nelson DR; Sulkowski MS; Everson GT; Lambiase LR; Wiesner RH; Dickson RC; Post AB; Redfield RR; Davis GL; Neumann AU; Osborn BL; Freimuth WW; Subramanian GM
    Antivir Ther; 2006; 11(1):35-45. PubMed ID: 16518958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential versus concomitant administration of ribavirin and interferon alfa-n3 in patients with chronic hepatitis C not responding to interferon alone: results of a randomized, controlled trial.
    Sostegni R; Ghisetti V; Pittaluga F; Marchiaro G; Rocca G; Borghesio E; Rizzetto M; Saracco G
    Hepatology; 1998 Aug; 28(2):341-6. PubMed ID: 9695995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
    Bargiggia S; Thorburn D; Anderloni A; Ardizzone S; Giorgi A; Bianchi Porro G; Parente F
    Aliment Pharmacol Ther; 2005 Aug; 22(3):209-15. PubMed ID: 16091058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of side effects of interferon-alpha in 72 patients treated for chronic active hepatitis C].
    Duché A; Decocq G; Capron-Chivrac D; Andréjak M
    Therapie; 1995; 50(5):419-23. PubMed ID: 8571279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychiatric side effects of HCV therapy and their treatment: focus on IFN alpha-induced depression.
    Hauser P
    Gastroenterol Clin North Am; 2004 Mar; 33(1 Suppl):S35-50. PubMed ID: 15081102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II clinical trial of combined natural interferon-beta plus recombinant interferon-gamma treatment of chronic hepatitis B.
    Musch E; Högemann B; Gerritzen A; Fischer HP; Wiese M; Kruis W; Malek M; Gugler R; Schmidt G; Huchzermeyer H; Gerlach U; Dengler HJ; Sauerbruch T
    Hepatogastroenterology; 1998; 45(24):2282-94. PubMed ID: 9951911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot study of interferon gamma for chronic hepatitis C.
    Soza A; Heller T; Ghany M; Lutchman G; Jake Liang T; Germain J; Hsu HH; Park Y; Hoofnagle JH
    J Hepatol; 2005 Jul; 43(1):67-71. PubMed ID: 15913831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major depressive disorder with psychotic features induced by interferon-alpha treatment for hepatitis C in a polydrug abuser.
    Kalyoncu OA; Tan D; Mirsal H; Pektas O; Beyazyurek M
    J Psychopharmacol; 2005 Jan; 19(1):102-5. PubMed ID: 15671136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic paranoid psychosis and dementia following interferon-alpha treatment of hepatitis C: a case report.
    Drozdz W; Borkowska A; Wilkosc M; Halota W; Dybowska D; Rybakowski JK
    Pharmacopsychiatry; 2007 Jul; 40(4):146-8. PubMed ID: 17694476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ophthalmologic side effects during alpha-interferon therapy for viral hepatitis.
    d'Alteroche L; Majzoub S; Lecuyer AI; Delplace MP; Bacq Y
    J Hepatol; 2006 Jan; 44(1):56-61. PubMed ID: 16223542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of autoimmune thyroiditis in interferon-alpha treated and untreated patients with chronic hepatitis C virus infection.
    Rocco A; Gargano S; Provenzano A; Nardone M; De Sanctis GM; Altavilla N; Chircu LV; Grimaldi F
    Neuro Endocrinol Lett; 2001; 22(1):39-44. PubMed ID: 11335878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups.
    Schaefer M; Schmidt F; Folwaczny C; Lorenz R; Martin G; Schindlbeck N; Heldwein W; Soyka M; Grunze H; Koenig A; Loeschke K
    Hepatology; 2003 Feb; 37(2):443-51. PubMed ID: 12540795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.